Skip to content

Pain Trajectory and Transcutaneous Electrical Acupoint Stimulation After Thoracoscopic Cardiac Surgery

Pain Trajectory and Transcutaneous Electrical Acupoint Stimulation After Thoracoscopic Cardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097806
Enrollment
Unknown
Registered
2025-02-26
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Experimental group:Perioperative transcutaneous electrical acupoint stimulation for perioperative thoracoscopic cardiac surgery on the basis of conventional care in the control group.

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing elective thoracoscopic valve or (and) coronary artery bypass grafting. (2) Aged between 18 and 85 years. (3) Conscious, with stable vital signs, normal comprehension, no expressive disorders, and able to cooperate with treatment.

Exclusion criteria

Exclusion criteria: (1) Contraindications to TEAS, including scarring, skin damage, or infection at the irritation site, as well as the presence of implanted electronic devices such as pacemakers. (2) Presence of acute or chronic pain in the preoperative surgical area. (3) A confirmed diagnosis of severe dysfunction of the brain, liver, or kidneys. (4) Serious cardiac arrhythmias, including severe sinus bradycardia or class II or higher atrioventricular block. (5) Significantly abnormal coagulation function, severe immune system disorders, or infectious diseases. (6) Communication disorders resulting from severe central nervous system diseases. (7) History of addiction to analgesic medications. (8) Patients requiring conversion to open-chest surgery during the procedure. (9) Participation in other interventional studies.

Design outcomes

Primary

MeasureTime frame
Acute postoperative pain;

Secondary

MeasureTime frame
Incidence of chronic postoperative pain;Proportion of patients with neuropathic pain among patients with chronic postoperative pain;sleep quality;anxiety;Duration of mechanical ventilation;ICU stays;Total length of stay;Chest tube retention time;The proportion and dosage of postoperative rescue analgesia;Intraoperative anaesthetic dosage;postoperative pain;

Countries

China

Contacts

Public ContactLin Yanjuan

Fujian Medical University Union Hospital

fjxhyjl@163.com+86 591 8621 8336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026